IMR Press / FBL / Volume 12 / Issue 2 / DOI: 10.2741/2099

Frontiers in Bioscience-Landmark (FBL) is published by IMR Press from Volume 26 Issue 5 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with Frontiers in Bioscience.

Open Access Article

The role of membrane ion transport proteins in cerebral ischemic damage

Show Less
1 Dept. of Neurosurgery, Univ. of Wisconsin School of Medicine and Public Health, Madison, WI 53792, USA
2 Dept. of Physiology, Univ. of Wisconsin School of Medicine and Public Health, Madison, WI 53792
Academic Editor:Wei Dai
Front. Biosci. (Landmark Ed) 2007, 12(2), 762–770; https://doi.org/10.2741/2099
Published: 1 January 2007
(This article belongs to the Special Issue Cell cycle checkpoint control)
Abstract

Loss of ion homeostasis plays a central role in pathogenesis of ischemic cell damage. Ischemia-induced perturbation of ion homeostasis leads to intracellular accumulation of Ca2+ and Na+ and subsequent activation of proteases, phospholipases, and formation of oxygen and nitrogen free radicals. This signal transduction cascade results in long-term functional and structural changes in membrane and cytoskeletal integrity and eventual cell death. Both ion conductances and ion transporters could affect ion homeostasis. Considerable research effort has been centered on roles of passive fluxes via cation and anion conductances in cerebral ischemic damage. This review will instead focus on the recent studies into the role of secondary active transport proteins in ischemia-induced dissipation of ion homeostasis. Secondary active ion transport proteins are a membrane protein-mediated solute transport mechanism that derives its energy from the combined chemical gradients of the transported ions. They are important in maintaining steady-state intracellular ion concentrations. These include Na+-dependent chloride transport (NKCC), Na+/H+ exchange (NHE), and Na+/Ca2+ exchange (NCX). Results from both in vitro and in vivo experimental studies suggest that these ion transport proteins are potential targets to reduce or prevent ischemia-mediated loss of ion homeostasis.

Share
Back to top